|Previous Section||Index||Home Page|
8 Jan 2002 : Column: 666W
Yvette Cooper: The information requested is not available. Individuals will generally not be aware of the presence of these conditions. It has been estimated that one in three women and one in 12 men over age 50 have osteoporosis.
Jacqui Smith: It has recently been estimated that in the United Kingdom some 180,000 people suffer sight loss due to age-related macular degeneration (AMD). It is possible that gene therapy may indeed one day be used to halt or even prevent AMD. The results of a number of pre-clinical research studies have been published, and these studies do look promising. However, it is too early to say for certain whether these specific approaches will ultimately lead to cures for patients with AMD.
Here in the UK, before moving into clinic to test such approaches in human subjects, the approval of our national supervisory body, the Gene Therapy Advisory Committee (GTAC) would be required. GTAC would base their decision as to the acceptability of any such trial on the medical and scientific merits of the research proposed and carefully weighing the potential benefits and risks to patients.
Mr. Burns: To ask the Secretary of State for Health how much funding for health care per patient there is in the parliamentary constituencies of (a) Sedgefield, (b) West Chelmsford, (c) South West Surrey and (d) North West Hampshire. 
Mr. Hutton: Health authorities receive allocations to commission healthcare for their population. The health authorities for these parliamentary constituencies, and their allocations per weighted head of population in 200102, are shown in the table.
8 Jan 2002 : Column: 667W
|Parliamentary constituency||Health authority||200102(33) (£)|
|West Chelmsford||North Essex||728|
|South west Surrey||West Surrey||749|
|North west Hampshire||North and mid Hampshire||736|
(33) Allocation per weighted head of population
Jacqui Smith: We have received just over 300 letters about the Diabetes National Service Framework since 15 October when we announced the changed plans for its publication. The Diabetes NSF standards were published on 14 December and have been widely welcomed.
|England at 30 September 2000||Numbers||Numbers per 100,000 population|
|All NHS doctors||97,440||194.9|
|All GMPs (including GP Retainers)(34)||31,370||62.7|
|All HCHS Staff(35)||66,070||132.1|
(34) General Medical Practitioners (including GP Retainers) includes Unrestricted Principals, PMS Salaried GPs, PMS Contracted GPs, Restricted Principals, Assistants, GP Registrars, Salaried Doctors (Para 52 SFA), and PMS Others.
(35) Excludes Medical Hospital Practitioners and Medical Clinical Assistants, most of whom are also General Practitioners working part-time in hospitals.
Figures are rounded to the nearest 10.
Unrounded figures were used in all calculations.
These are NHS doctors only. These figures do not show private practice doctors or doctors that are registered but not working.
Department of Health medical and dental workforce census
Department of Health General and Personal Medical Services Statistics.
Mr. Heald: To ask the Secretary of State for Health how many episodes of in-patient care were purchased by the NHS in the independent mental health sector in (a) 199798, (b) 19992000, (c) 200001 and (d) this financial year to date. 
8 Jan 2002 : Column: 668W
any one time, (ii) during the course of the most recent year for which figures are available and (iii) during their lifetimes; 
(3) what proportion of those suffering (a) a disabling anxiety disorder, (b) clinical depression, (c) manic depression and (d) schizophrenia were (i) men and (ii) women, in the most recent year for which figures are available; 
(4) what his estimate is of the (a) number and (b) proportion of people who suffer manic depression (i) at any one time, (ii) during the course of the most recent year for which figures are available and (iii) during their lifetimes; 
(5) what his assessment is of the proportion of people who will develop (a) a disabling anxiety disorder, (b) a phobia and (c) an obsessive compulsive disorder during their lives; 
(6) what assessment he has made of the prevalence of (a) psychosis, (b) psychiatric illness and (c) neurotic disorders among adults living in private households. 
Jacqui Smith: The Office for National Statistics is responsible for compiling, analysing and disseminating information relating to United Kingdom economic, social and demographic statistics. Their report 'Psychiatric morbidity among adults living in private households, 2000' is available on the website at www.statistics.gov.uk. Along with others due for publication next year, the report contains valuable information about the prevalence of mental disorders among adults in private households.
Mr. Heald: To ask the Secretary of State for Health what number and proportion of the (a) general and (b) adult population presented with mental health problems to the NHS in the most recent year for which figures are available. 
Jacqui Smith: The Office for National Statistics is the Government agency responsible for compiling, analysing and disseminating information relating to estimates of numbers in the general population with mental health problems, and the proportion using specific services. Their recent report "Psychiatric morbidity among adults living in private households, 2000" is available on the website at www.statistics.gov.uk
Mr. Heald: To ask the Secretary of State for Health what plans he has for the proposed Children's National Service Framework with regard to mental health services for children and young persons. 
Jacqui Smith: One of the specific areas to be addressed in the Children's National Service Framework is child and adolescent mental health services. Detailed work to develop this strand of the service framework will take place in an external working group under the chairmanship of Mike Farrar, chief executive of Tees health authority, and Dr. Caroline Lindsey, consultant psychiatrist at the Tavistock clinic. The first meeting of the external working group is scheduled for January.
8 Jan 2002 : Column: 669W
Mr. Heald: To ask the Secretary of State for Health of those discharged from hospital in the most recent year for which figures are available after treatment for alcohol and drug related problems, what proportions of (a) men and (b) women were diagnosed as suffering from (i) disabling anxiety disorder, (ii) clinical depression, (iii) manic depression and (iv) schizophrenia. 
The table shows the estimated number of finished consultant episodes with a primary diagnosis of mental and behavioural disorder due to psychoactive substance use, in England, for 19992000, the latest year for which data are available. These figures have a provisional status as no adjustments have yet been made for shortfalls in data.
|Mental and behavioural disorders due to the use of psychoactive substances F10-F19 (excluding F17, tobacco)||Persons||Male||Female|
|Total F10-F19 (excluding F17)||42,600||29,360||12,940|
|Sedatives or hypnotics (F13)||250||130||120|
|Other stimulants including caffeine (F15)||640||440||190|
|Volatile solvents (F18)||70||60||10|
|Multiple drug use and use of other psychoactive substances (F19)||3,160||2,320||820|
1. Persons category includes 'Unknown' and 'not specified' sex categories.
2. Data for 19992000 have not been grossed for coverage and have a provisional status.
3. Figures have been rounded to the nearest 10 for confidentiality purposes.
4. Figures may not add up due to rounding.
5. Codes have been taken from the 'International Statistical Classification of Diseases and Related Health Problems' Tenth Revision (ICD-10).
6. Of the 42,600 episodes detailed above 2,340 have a primary diagnosis of psychotic disorder.
7. The diagnosis of psychotic disorder includes a cluster of psychotic phenomena that occur during or following psychoactive substance use but that are not explained on the basis of acute intoxication alone and do not form part of a withdrawal state. The disorder is characterised by hallucinations, perceptual distortions, delusions, psychomotor disturbances, and an abnormal affect, which may range from intense fear to ecstasy.
|Next Section||Index||Home Page|